Evidence map›Paper›PMID 35757812›Full record

ReviewFrontiers in bioengineering and biotechnology2022

Recent Advances of Intraocular Lens Materials and Surface Modification in Cataract Surgery.

Chenqi Luo, Hanle Wang, Xinyi Chen, Jingjie Xu, Houfa Yin, Ke Yao

Abstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Article
  2. Article
  3. Advances in cataract surgery: is a new era on the horizon?Current opinion in ophthalmology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Future Frontiers in Bioinspired Implanted Biomaterials.Advanced materials (Deerfield Beach, Fla.) · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Application of Silicone in Ophthalmology: A Review.Materials (Basel, Switzerland) · 2024
    Review
  17. Article
  18. Seeing the Future: A Review of Ocular Therapy.Bioengineering (Basel, Switzerland) · 2024
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chenqi LuoEye Center of the Second Affiliated Hospital, Medical College of Zhejiang University, Hangzhou, China.
Hanle WangEye Center of the Second Affiliated Hospital, Medical College of Zhejiang University, Hangzhou, China.
Xinyi ChenEye Center of the Second Affiliated Hospital, Medical College of Zhejiang University, Hangzhou, China.
Jingjie XuEye Center of the Second Affiliated Hospital, Medical College of Zhejiang University, Hangzhou, China.
Houfa YinEye Center of the Second Affiliated Hospital, Medical College of Zhejiang University, Hangzhou, China.
Ke YaoEye Center of the Second Affiliated Hospital, Medical College of Zhejiang University, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Advances in cataract surgery have increased the demand for intraocular lens (IOL) materials. At present, the progress of IOL materials mainly contains further improving biocompatibility, providing better visual quality and adjustable ability, reducing surgical incision, as well as dealing with complications such as posterior capsular opacification (PCO) and ophthalmitis. The purpose of this review is to describe the research progress of relevant IOL materials classified according to different clinical purposes. The innovation of IOL materials is often based on the common IOL materials on the market, such as silicon and acrylate. Special properties and functions are obtained by adding extra polymers or surface modification. Most of these studies have not yet been commercialized, which requires a large number of clinical trials. But they provide valuable thoughts for the optimization of the IOL function.

Indexed as

biocompatibilitybiomaterialsintraocular lensposterior capsular opacificationsurface modification

Identifiers

PMID35757812
PMCPMC9213654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.